OPNT Annual Operating Expenses
$26.50 M
+$3.06 M+13.03%
31 December 2021
Summary:
As of January 23, 2025, OPNT annual total operating expenses is $26.50 million, with the most recent change of +$3.06 million (+13.03%) on December 31, 2021. During the last 3 years, it has fallen by -$6.71 million (-20.20%).OPNT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Operating Expenses
$9.63 M
-$3.54 M-26.91%
30 September 2022
Summary:
As of January 23, 2025, OPNT quarterly total operating expenses is $9.63 million, with the most recent change of -$3.54 million (-26.91%) on September 30, 2022. Over the past year, it has increased by +$2.61 million (+37.14%).OPNT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.0% | +37.1% |
| 3 y3 years | -20.2% | +90.8% |
| 5 y5 years | +200.7% | +71.1% |
OPNT Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -20.2% | -29.0% |
Opiant Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $9.63 M(-26.9%) |
| June 2022 | - | $13.17 M(-2.8%) |
| Mar 2022 | - | $13.55 M(+53.3%) |
| Dec 2021 | $26.50 M(+13.0%) | $8.84 M(+25.9%) |
| Sept 2021 | - | $7.02 M(+41.5%) |
| June 2021 | - | $4.96 M(-12.6%) |
| Mar 2021 | - | $5.68 M(-23.8%) |
| Dec 2020 | $23.45 M(+19.6%) | $7.45 M(+25.8%) |
| Sept 2020 | - | $5.92 M(+16.4%) |
| June 2020 | - | $5.09 M(+2.0%) |
| Mar 2020 | - | $4.99 M(+2.4%) |
| Dec 2019 | $19.60 M(-41.0%) | $4.87 M(-3.6%) |
| Sept 2019 | - | $5.05 M(+16.1%) |
| June 2019 | - | $4.35 M(-18.6%) |
| Mar 2019 | - | $5.34 M(-59.3%) |
| Dec 2018 | $33.21 M(+276.9%) | $13.12 M(+182.1%) |
| Sept 2018 | - | $4.65 M(+5.0%) |
| June 2018 | - | $4.43 M(-59.8%) |
| Mar 2018 | - | $11.01 M(+95.6%) |
| Dec 2017 | $8.81 M(-22.4%) | - |
| Oct 2017 | - | $5.63 M(+57.5%) |
| July 2017 | $11.35 M(-35.6%) | $3.57 M(+12.2%) |
| Apr 2017 | - | $3.18 M(+9.9%) |
| Jan 2017 | - | $2.90 M(+70.4%) |
| Oct 2016 | - | $1.70 M(+24.7%) |
| July 2016 | $17.64 M(+108.7%) | $1.36 M(-37.8%) |
| Apr 2016 | - | $2.19 M(-23.3%) |
| Jan 2016 | - | $2.86 M(-74.5%) |
| Oct 2015 | - | $11.22 M(+367.8%) |
| July 2015 | $8.45 M(-25.2%) | $2.40 M(+22.4%) |
| Apr 2015 | - | $1.96 M(-41.1%) |
| Jan 2015 | - | $3.33 M(+338.2%) |
| Oct 2014 | - | $760.10 K(-81.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2014 | $11.30 M(+28.4%) | $4.13 M(+654.4%) |
| Apr 2014 | - | $546.90 K(-89.3%) |
| Jan 2014 | - | $5.09 M(+230.7%) |
| Oct 2013 | - | $1.54 M(+20.4%) |
| July 2013 | $8.81 M(-28.6%) | $1.28 M(+120.6%) |
| Apr 2013 | - | $579.60 K(-90.7%) |
| Jan 2013 | - | $6.24 M(+751.5%) |
| Oct 2012 | - | $733.00 K(-54.3%) |
| July 2012 | $12.34 M(+30.7%) | $1.60 M(+10.5%) |
| Apr 2012 | - | $1.45 M(-68.3%) |
| Jan 2012 | - | $4.57 M(-2.8%) |
| Oct 2011 | - | $4.71 M(+70.5%) |
| July 2011 | $9.44 M(+367.9%) | $2.76 M(-48.9%) |
| Apr 2011 | - | $5.40 M(+442.8%) |
| Jan 2011 | - | $994.70 K(+253.0%) |
| Oct 2010 | - | $281.80 K(-41.8%) |
| July 2010 | $2.02 M(>+9900.0%) | $484.40 K(+122.8%) |
| Apr 2010 | - | $217.40 K(-82.5%) |
| Jan 2010 | - | $1.24 M(+1525.7%) |
| Oct 2009 | - | $76.20 K(+4382.4%) |
| July 2009 | $14.70 K(-17.9%) | $1700.00(-60.5%) |
| Apr 2009 | - | $4300.00(+30.3%) |
| Jan 2009 | - | $3300.00(-38.9%) |
| Oct 2008 | - | $5400.00(-55.0%) |
| July 2008 | $17.90 K(-46.7%) | $12.00 K(+531.6%) |
| Apr 2008 | - | $1900.00(-42.4%) |
| Jan 2008 | - | $3300.00(+371.4%) |
| Oct 2007 | - | $700.00(-94.2%) |
| July 2007 | $33.60 K | $12.10 K(+137.3%) |
| Apr 2007 | - | $5100.00(+750.0%) |
| Jan 2007 | - | $600.00(-92.9%) |
| Oct 2006 | - | $8400.00(+1580.0%) |
| Apr 2006 | - | $500.00(>+9900.0%) |
| Jan 2006 | - | $0.00 |
FAQ
- What is Opiant Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual operating expenses year-on-year change?
- What is Opiant Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly operating expenses year-on-year change?
What is Opiant Pharmaceuticals annual total operating expenses?
The current annual operating expenses of OPNT is $26.50 M
What is the all time high annual operating expenses for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual total operating expenses is $33.21 M
What is Opiant Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, OPNT annual total operating expenses has changed by +$3.06 M (+13.03%)
What is Opiant Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of OPNT is $9.63 M
What is the all time high quarterly operating expenses for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly total operating expenses is $13.55 M
What is Opiant Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, OPNT quarterly total operating expenses has changed by +$2.61 M (+37.14%)